MoneyWorks4Me

Dr. Reddy's gets 2 observations from USFDA for Hyderabad Plant

28 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy's Laboratories’ Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad. The company has been issued a Form 483 with 2 observations. The company will address them comprehensively within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..